WINSTON ROY 4
4 · Pacira BioSciences, Inc. · Filed Nov 8, 2021
Insider Transaction Report
Form 4
WINSTON ROY
Chief Clinical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-11-04$48.15/sh+10,000$481,500→ 46,456 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-11-04−10,000→ 15,000 totalExercise: $48.15Exp: 2027-05-02→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years.